4WM-33674-12229
2 vaccinations
2 coded responses
11 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 352 / AL
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Moderna
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Diarrhea · Be unable to workAdult check-in
- 2021-01-14
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-15
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-01-17
-
2021-01-18
Survey response — days 1–6 daily, dose 1MedDRA: Panic attack — Feeling: Fair · HeadacheFree text: Panic attack during the nightMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-19
-
2021-01-22
Health check-in — day 7, dose 1Feeling: Fair · Fever · Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-01-27
- 2021-02-03
-
2021-02-10
Dose 2 — Moderna
-
2022-02-10
Survey response — 12 months, dose 2MedDRA: COVID-19, Dyspnoea, Fatigue, Memory impairment — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fatigue. Memory fog. COVID. Shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2022-02-10
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-11
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Moderna | |
| 2 | 2021-02-10 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-14 | priority 2/3 | |
| 2021-01-15 | priority 2/3 | |
| 2022-02-10 | Successful 2022-02-11 |
Participant prefers to complete VAERS report online |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Panic attack during the night
Release 11 — 12 months, dose 2
Symptoms: Fatigue. Memory fog. COVID. Shortness of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Memory impairment | · | · | ✓ |
| SRO | Panic attack | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release